Continental Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-15,000
Closed -$1.8M 165
2015
Q4
$1.8M Buy
15,000
+2,500
+20% +$289K 0.46% 67
2015
Q3
$1.35M Buy
+12,500
New +$1.55M 0.36% 81
2015
Q2
Sell
-8,000
Closed -$922K 163
2015
Q1
$922K Sell
8,000
-22,000
-73% -$2.63M 0.2% 108
2014
Q4
$3.36M Sell
30,000
-4,000
-12% -$422K 0.68% 45
2014
Q3
$3.22M Sell
34,000
-14,000
-29% -$1.26M 0.73% 35
2014
Q2
$4.12M Buy
48,000
+23,000
+92% +$1.75M 0.96% 29
2014
Q1
$1.75M Sell
25,000
-20,000
-44% -$1.58M 0.45% 63
2013
Q4
$3.8M Buy
45,000
+15,000
+50% +$1.19M 0.83% 28
2013
Q3
$2.31M Sell
30,000
-6,000
-17% -$420K 0.57% 52
2013
Q2
$2.11M Buy
+36,000
New +$2.17M 0.59% 51

Other funds holding CELG

Continental Advisors's CELG Position: Q4 2015 in Review

Continental Advisors sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 2,500 shares — an estimated $289K sold.

Continental Advisors first reported a position in CELG in Q2 2013 and held it in 3 quarters. The position peaked at $585K in Q2 2013. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Continental Advisors reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
  • Continental Advisors sold 2,500 Celgene Corp shares in Q4 2015, an estimated $289K.
  • Continental Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 3 quarters.
  • Continental Advisors's Celgene Corp position peaked at $585K in Q2 2013.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Continental Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.